As the voice for all infusion providers across the nation, NICA has new guidance on preparing for and navigating potential disruptions to supply distribution or supply […]
The Corporate Practice of Medicine (“CPOM”) doctrine is one of the relatively significant legal issues to consider for corporate entities seeking to provide healthcare services.
Infusion providers focused on providing excellent patient care often ask themselves, “How do I design a clinical training program that focuses on clinician competency and excellent patient care?”
By: Tiffani Bouchard, CCS Managing JW and JZ Modifiers When Billing Single-Dose Drugs Managing JW and JZ modifiers when billing single-dose drugs can be challenging. As […]
By: Pamela McIntyre, CRNI, IgCN, OCN, and VA-BC Maximizing Efficiency in Ambulatory Infusion Centers When it comes to maximizing efficiency in ambulatory infusion centers, one of […]
By: Michael Rigas, Pharm.D., FNHIA Biosimilars are also known as follow-on biologics or subsequent-entry biologics. They are FDA-approved copies of the original “innovator” drug product that […]
By: Ty Bello, BS, RCC The objective of this article is to provide information with application so you, as an Independent Ambulatory Infusion Center, can either […]
By: Kay Coulter, RN, CRNI, VA-BC In the insurance industry there’s a saying about how you don’t know you’re facing litigation until it’s too late. Ambulatory […]